论文信息 - Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial - 字舞流文

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial

H. Russnes | B. Naume | Ø. Garred | E. Jakobsen | J. Kyte | S. Chauhan | C. Dunn | B. Gilje | J. Lømo | R. Falk | S. X. Raj | C. Bjerre | A. Røssevold | N. K. Andresen | Thea Jahr | R. Mathiesen | R. Lereim | Bjørnar Gilje